BTI
FRTX

Blue Trust Inc’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Blue Trust Inc’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-916
Closed -$1K – 2812
2023
Q4 		$1K Hold
916
– – ﹤0.01% 2461
2023
Q3 		$1K Hold
916
– – ﹤0.01% 1991
2023
Q2 		$1K Hold
916
– – ﹤0.01% 1971
2023
Q1 		$1K Hold
916
– – ﹤0.01% 2249
2022
Q4 		$2K Sell
916
-40,327
-98% -$71.2K ﹤0.01% 1985
2022
Q3 		$5K Buy
41,243
+39,876
+2,917% +$115K ﹤0.01% 1596
2022
Q2 		$16K Buy
+1,367
New +$12.4K ﹤0.01% 1053

Other funds holding FRTX

OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $329M AUM 22.88% 1-Year Est. Return

Blue Trust Inc's FRTX Position: Q1 2024 in Review

Blue Trust Inc sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2024, closing a stake of 916 shares — an estimated $1K sold.

Blue Trust Inc first reported a position in FRTX in Q2 2022 and held it in 7 quarters. The position peaked at $16K in Q2 2022. 1 fund tracked by Wall St. Rank holds FRTX as of Q1 2024.

  • Blue Trust Inc reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Blue Trust Inc sold 916 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1K.
  • Blue Trust Inc first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Blue Trust Inc's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $16K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Blue Trust Inc's 13F filing for Q1 2024, filed 1 May 2024.